Patrick W. Serruys1*, MD, PhD; Yoshinobu Onuma1, MD; Scot Garg1, MD, MRCP; Giovanna Sarno1, MD, PhD; Marcel van den Brand2, MD, PhD; Arie-Pieter Kappetein3, MD, PhD; Nic Van Dyck4, RN; Michael Mack5, MD; David Holmes6, MD; Ted Feldman7, MD; Marie-Claude Morice8, MD; Antonio Colombo9, MD; Eric Bass10, PhD; Katrin Leadley10, MD; Keith D Dawkins10, MD; Gerrit-Anne van Es11, PhD; Marie-Angèle M. Morel11, BSc; Friedrich W. Mohr12, MD
1.Department of Interventional Cardiology, Erasmus Medical Center, Thoraxcenter Rotterdam, The Netherlands; 2. Ouderkerk aan den IJssel, The Netherlands; 3. Department of Cardiothoracic Surgery, Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherl
Aims: The SYNTAX™ score has been designed to better anticipate the risks of percutaneous or surgical revascularisation, taking into account the functional impact of the coronary circu